i
FLUCELVAX quadrivalent (ccIIV4) a phase III randomized controlled trial : immunogenicity & safety results in young children (6 through 47 months of age)
-
06/24/2021
Series: ACIP meeting Influenza
Details:
-
Personal Author:
-
Corporate Authors:
-
Conference Authors:
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Collection(s):
-
Main Document Checksum:urn:sha256:e96a5830759941b9ea9bd9bb26ef6618bed8d299820203f77291b9070b3a0a02
-
File Type:
Supporting Files
-
No Additional Files
More +
Related Documents
More +
You May Also Like
Checkout today's featured content at stacks.cdc.gov